ArticleFrontiers in oncology2021

Population-Based Study of Docetaxel or Abiraterone Effectiveness and Predictive Markers of Progression Free Survival in Metastatic Castration-Sensitive Prostate Cancer.

Juan Briones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.